Bicyclo <3,2,1> octanol-(3) | 29804-62-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Bicyclo <3,2,1> octanol-(3)
• 英文别名: Bicyclo[3.2.1]octan-3-ol
• CAS: 29804-62-4
• 化学式: C₈H₁₄O
• 分子量: 126.199
• InChiKey: HREZEXWGSYQUAI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  Bicyclo <3,2,1> octanol-(3) 、 异香兰素 、 三苯基膦 生成 3-(3-bicyclo[3.2.1]octanyloxy)-4-methoxybenzaldehyde
  参考文献：
  名称：

  SACCOMANO, NICHOLAS A.;VINICK, FREDERIC J.;KOE, KENNETH B.;NIELSEN, JANN +, J. MED. CHEM., 34,(1991) N, C. 291-298

  摘要：

  DOI：
• 作为产物：
  描述：

  双环[3,2,1]辛烷-3-酮 、 环己烷 以52%的产率得到
  参考文献：
  名称：

  MOMOSE, TAKEFUMI;MURAOKA, OSAMU;MUSADA, KIKUO, CHEM. AND PHARM. BULL., 1984, 32, N 9, 3730-3733

  摘要：

  DOI：

文献信息

• [EN] PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6<br/>[FR] COMPOSÉS DE LA PYRROLOPYRIMIDINE UTILISÉS EN TANT QU'INHIBITEURS DES CDK4/6
  申请人：NOVARTIS AG

  公开号：WO2011101409A1

  公开（公告）日：2011-08-25

  The invention is directed to novel pyrrolopyrimidine compounds of formula (I) wherein R1, R2Y, R4, R8- R11, A and L are defined herein and to salts, including pharmaceutically acceptable salts thereof. The compounds of the present invention are CDK4/6 inhibitors and could be useful in the treatment of diseases and disorders mediated by CDK4/6, such as cancer, including mantle cell lymphoma, liposarcoma, non small cell lung cancer, melanoma, squamous cell esophageal cancer and breast cancer. The invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CDK4/6 activity and to the treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  本发明涉及一种新型吡咯吡嘧啶化合物，其化学式为（I），其中R1、R2Y、R4、R8-R11、A和L的定义如下，以及其盐，包括其药用可接受盐。本发明的化合物是CDK4/6抑制剂，可用于治疗由CDK4/6介导的疾病和紊乱，如癌症，包括袍细胞淋巴瘤、脂肪肉瘤、非小细胞肺癌、黑色素瘤、鳞状细胞食管癌和乳腺癌。本发明还涉及包含本发明化合物的药物组合物。此外，本发明还涉及通过使用本发明化合物或包含本发明化合物的药物组合物来抑制CDK4/6活性和治疗相关疾病的方法。
• Methods for One-Pot N-Demethylation/N-Functionalization of Morphine and Tropane Alkaloids
  申请人：Hudlicky Tomas

  公开号：US20110313163A1

  公开（公告）日：2011-12-22

  The present invention provides a method for the N-demethylation and N-functionalization of an N-methylated heterocycle such as a morphine alkaloid or tropane alkaloid. The method comprises reacting the heterocycle with an functionalization agent in the presence of a transition metal catalyst in air or in the presence of an oxidant.

  本发明提供了一种用于N-去甲基化和N-官能化的方法，该方法适用于N-甲基杂环化合物，例如吗啡生物碱或曲剪生物碱。该方法包括在过渡金属催化剂的存在下，在空气中或在氧化剂的存在下，将杂环化合物与官能化试剂反应。
• METHOD FOR THE N-DEMETHYLATION OF N-METHYL HETEROCYCLES
  申请人：Scammells Peter John

  公开号：US20120226043A1

  公开（公告）日：2012-09-06

  The present invention provides methods of N-demethylating, N-methylated heterocycles and N-methyl, N-oxide heterocycles using a transition metal with an oxidation state of zero, ferrocene or substituted derivatives thereof, or Cr 3+ . N-demethylated heterocycles prepared by the methods of the present invention are also provided.

  本发明提供了使用氧化态为零的过渡金属、二茂铁或其取代衍生物或Cr3+对N-甲基化杂环和N-甲基、N-氧化物杂环进行N-去甲基化的方法。本发明还提供了通过本发明方法制备的N-去甲基化杂环。
• INDAZOLE COMPOUNDS AS KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
  申请人：University Health Network

  公开号：US20140371202A1

  公开（公告）日：2014-12-18

  The present teaching provide indazole compounds represented by Structural Formulae (I) or (I′) or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof as protein kinase inhibitors, such as TTK protein kinase, polo-like kinase 4 (PLK4) and Aurora kinases having anticancer activity against breast cancer cells, colon cancer cells, and ovarian cancer cells.

  本教学提供由结构式（I）或（I'）所代表的吲唑化合物或其药学上可接受的盐。还描述了制备药物组合物和使用方法，作为蛋白激酶抑制剂，例如TTK蛋白激酶，极化样激酶4（PLK4）和极化激酶，对乳腺癌细胞，结肠癌细胞和卵巢癌细胞具有抗癌活性。
• METHODS FOR ONE-POT N-DEMETHYLATION/N-FUNCTIONALIZATION OF MORPHINE AND TROPANE ALKALOIDS
  申请人：Brock University

  公开号：US20150152120A1

  公开（公告）日：2015-06-04

  The present invention provides a method for the N-demethylation and N-functionalization of an N-methylated heterocycle such as a morphine alkaloid or tropane alkaloid. The method comprises reacting the heterocycle with an functionalization agent in the presence of a transition metal catalyst in air or in the presence of an oxidant.

  本发明提供了一种对N-甲基杂环，如吗啡生物碱或曲柳生物碱进行N-脱甲基化和N-官能化的方法。该方法包括在空气中或在氧化剂存在下，将杂环与官能化试剂在过渡金属催化剂的存在下反应。